Timothy C Thompson Selected Research

Timothy C Thompson Research Topics

Disease

76	Prostatic Neoplasms (Prostate Cancer) 07/2021 - 01/2002
49	Neoplasms (Cancer) 10/2022 - 01/2002
10	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2003
5	Glioma (Gliomas) 04/2014 - 01/2008
4	Disease Progression 01/2020 - 03/2003
3	Adenocarcinoma 01/2021 - 01/2018
3	Prostatic Intraepithelial Neoplasia 02/2012 - 11/2002
3	Margins of Excision 03/2005 - 03/2003
3	Carcinoma (Carcinomatosis) 03/2005 - 03/2003
2	Bites and Stings (Sting) 01/2021 - 11/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 01/2016
2	Infections 04/2007 - 05/2004
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 08/2006 - 09/2003
2	Lung Neoplasms (Lung Cancer) 09/2004 - 05/2002
1	Anorexia 10/2019
1	Neutropenia 10/2019
1	Thrombocytopenia (Thrombopenia) 10/2019
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2019
1	Fatigue 10/2019
1	Dehydration (Water Stress) 10/2019
1	Thrombocytopenia 1 10/2019
1	Thyroid Neoplasms (Thyroid Cancer) 01/2019
1	Hypoxia (Hypoxemia) 01/2018
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2017
1	Ovarian Neoplasms (Ovarian Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

20	Caveolin 1IBA 01/2020 - 10/2002
13	Proteins (Proteins, Gene)FDA Link 04/2014 - 01/2003
12	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2002
11	AndrogensIBA 01/2021 - 10/2002
8	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 11/2002
5	olaparibIBA 01/2021 - 05/2017
5	Biological ProductsIBA 01/2019 - 01/2006
5	Androgen Receptors (Androgen Receptor)IBA 05/2017 - 06/2010
4	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2022 - 05/2014
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 01/2017
4	enzalutamideIBA 11/2019 - 03/2015
4	Pharmaceutical PreparationsIBA 10/2019 - 11/2008
4	AntibodiesIBA 04/2012 - 04/2003
4	Messenger RNA (mRNA)IBA 02/2012 - 05/2002
3	Ganciclovir (Cytovene)FDA LinkGeneric 07/2021 - 04/2006
3	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 01/2002
3	Aurora Kinase AIBA 01/2018 - 06/2013
3	Small Interfering RNA (siRNA)IBA 09/2013 - 12/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2012 - 11/2009
3	ParaffinIBA 03/2005 - 11/2002
2	Thymidine KinaseIBA 07/2021 - 04/2007
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2008
2	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2019
2	AntigensIBA 01/2021 - 05/2015
2	Mitochondrial DNA (mtDNA)IBA 01/2020 - 12/2015
2	LipidsIBA 01/2020 - 07/2016
2	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 11/2019 - 03/2015
2	PlatinumIBA 10/2019 - 01/2017
2	Therapeutic UsesIBA 01/2018 - 02/2014
2	Follistatin-Related ProteinsIBA 01/2018 - 01/2016
2	Hormones (Hormone)IBA 07/2016 - 04/2007
2	Neoplasm Antigens (Tumor Antigens)IBA 05/2015 - 05/2003
2	Androgen Antagonists (Antiandrogens)IBA 03/2015 - 06/2010
2	perifosineIBA 04/2011 - 08/2008
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 11/2009 - 05/2006
2	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2008 - 01/2006
2	Interleukin-12 (IL 12)IBA 05/2004 - 11/2003
1	NAD (NADH)IBA 10/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2022
1	B7-H1 AntigenIBA 01/2021
1	abemaciclibIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	palbociclibIBA 01/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 11/2020
1	InterferonsIBA 11/2020
1	SphingolipidsIBA 01/2020
1	CeramidesIBA 01/2020
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2020
1	GlycosphingolipidsIBA 01/2020
1	SphingomyelinsIBA 01/2020
1	CholesterolIBA 01/2020
1	dinaciclibIBA 11/2019
1	talazoparibIBA 11/2019
1	sofalcone (Solon)IBA 10/2019
1	taxaneIBA 10/2019
1	cabazitaxel FDA Link 10/2019
1	Carboplatin (JM8)FDA LinkGeneric 10/2019
1	Drug CombinationsIBA 10/2019
1	Chemokine ReceptorsIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	danusertibIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Testosterone (Sustanon)FDA Link 03/2017
1	3- (carbamoylamino)- 5- (3- fluorophenyl)- N- (3- piperidyl)thiophene- 2- carboxamideIBA 01/2017
1	Docetaxel (Taxotere)FDA Link 06/2015
1	abirateroneIBA 03/2015
1	apalutamideIBA 03/2015

Therapy/Procedure

27	Therapeutics 01/2021 - 10/2002
15	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 11/2002
15	Castration 01/2021 - 09/2009
9	Radiotherapy 01/2021 - 01/2002
3	Drug Therapy (Chemotherapy) 01/2017 - 06/2015
3	Immunotherapy 12/2007 - 01/2003
2	Injections 01/2021 - 05/2003
1	Neoadjuvant Therapy 05/2015